Seattle Washington based Myosana Therapeutics is raising $6,400,479.00 in New Equity Investment.
Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Myosana Therapeutics is raising $6,400,479.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Nicholas Whitehead played a…